PAS
IMNN icon

Park Avenue Securities’s Imunon IMNN Stock Holding History

Park Avenue Securities’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-128
Closed -$14K – 1150
2021
Q4 		$14K Hold
128
– – ﹤0.01% 1098
2021
Q3 		$23K Hold
128
– – ﹤0.01% 1027
2021
Q2 		$32K Hold
128
– – ﹤0.01% 1012
2021
Q1 		$35K Hold
128
– – ﹤0.01% 947
2020
Q4 		$18K Hold
128
– – ﹤0.01% 842
2020
Q3 		$18K Hold
128
– – ﹤0.01% 736
2020
Q2 		$93K Buy
+128
New +$55.5K ﹤0.01% 672

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Park Avenue Securities's IMNN Position: Q1 2022 in Review

Park Avenue Securities sold out of Imunon (IMNN) in Q1 2022, closing a stake of 128 shares — an estimated $14K sold.

Park Avenue Securities first reported a position in IMNN in Q2 2020 and held it in 7 quarters. The position peaked at $93K in Q2 2020. 23 funds tracked by Wall St. Rank hold IMNN as of Q1 2022.

  • Park Avenue Securities reported no remaining Imunon position as of Q1 2022 after selling out during the quarter.
  • Park Avenue Securities sold 128 Imunon shares in Q1 2022, an estimated $14K.
  • Park Avenue Securities first reported a position in Imunon in Q2 2020 and held it in 7 quarters.
  • Park Avenue Securities's Imunon position peaked at $93K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q1 2022.

Based on Park Avenue Securities's 13F filing for Q1 2022, filed 29 Apr 2022.